Taraxasterol alleviates liver fibrosis by suppressing hepatic stellate cell activation via the HSD11B1-ERK MAPK signaling axis
Acta Biochimica et Biophysica Sinica · 01.08.2026
DOI: 10.3724/abbs.2026089 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biochimica et Biophysica Sinica, online erschienen am 03.08.2026. Verfasst von Peng Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Alcohol-related Liver Disease Center, the Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510630, Chin…. Die Arbeit nennt 35 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Alcohol-related Liver Disease Center, the Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510630, China.
- Guangdong Provincial Key Laboratory of Liver Disease Research, Guangzhou 510630, China.
Zitieren
APA
Wang, P., Zhou, H., Ding, Y., Chen, Y., Liu, H., Jiang, J., & Wu, B. (2026). Taraxasterol alleviates liver fibrosis by suppressing hepatic stellate cell activation via the HSD11B1-ERK MAPK signaling axis. Acta Biochimica et Biophysica Sinica. https://doi.org/10.3724/abbs.2026089
Vancouver
Wang P, Zhou H, Ding Y, Chen Y, Liu H, Jiang J, et al. Taraxasterol alleviates liver fibrosis by suppressing hepatic stellate cell activation via the HSD11B1-ERK MAPK signaling axis. Acta Biochimica et Biophysica Sinica. 2026. doi:10.3724/abbs.2026089
BibTeX
@article{Wang2026,
author = {Wang, Peng and Zhou, Haoxiong and Ding, Yuming and Chen, Yan and Liu, Huiling and Jiang, Jie and Wu, Bin},
title = {Taraxasterol alleviates liver fibrosis by suppressing hepatic stellate cell activation via the HSD11B1-ERK MAPK signaling axis},
journal = {Acta Biochimica et Biophysica Sinica},
year = {2026},
doi = {10.3724/abbs.2026089}
}
EUVIMED